Experimental trial research presented at the American College of Cardiology’s 71st Annual Scientific Session showed that the combinations of EPA/atorvastatin active metabolite (ATM) and of EPA/rosuvastatin (rosuva) reduced lipid oxidation by 86% and 75%, respectively (p<0.001) DUBLIN, Ireland and BRIDGEWATER, N.J., April 01, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc […]
Coronary/Structural Heart
Spacelabs Healthcare Showcases New Products at Upcoming American College of Cardiology Scientific Sessions and Expo
SNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare, a division of OSI Systems, Inc. (“OSI Systems”), today announced that it will be demonstrating new diagnostic cardiology products at the American College of Cardiology’s (“ACC”) 71st annual event. Attendees will have an opportunity to see new and recent offerings from Spacelabs Healthcare, including the Eclipse™ Pro […]
EDWARDS MITRIS RESILIA VALVE RECEIVES FDA APPROVAL FOR MITRAL REPLACEMENT SURGERIES
IRVINE, Calif., March 31, 2022 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart’s mitral position. The MITRIS RESILIA valve has a saddle-shaped sewing cuff that mimics the asymmetric […]
Vizient Medical Device Tech Watch Provides Trends in Transcatheter Valve Replacement and a Model for Assessing New Technology in Musculoskeletal Care
IRVING, Texas–(BUSINESS WIRE)–In its latest Medical Device Tech Watch, Vizient, Inc. provides updated trends in patient quality outcomes for transcatheter valve replacement, including insights for complications and physician expertise. In addition, this issue presents a technology adoption model for assessing the clinical and financial impact of various technologies in musculoskeletal care. The […]
CathWorks Presents New Data and Latest Innovations at ACC 2022
CathWorks FFRangio™ System outcomes study to be presented at ACC 2022 CathWorks announces the completion of more than 5,000 FFRangio cases globally KFAR-SABA, Israel and IRVINE, Calif., March 31, 2022 /PRNewswire/ — CathWorks announced today that the results of its most recent outcomes study on the CathWorks FFRangio™ system will be presented by Dr. Guy Witberg from Rabin Medical […]
Desert Oasis Healthcare Offers Eligible Members Digital Cardiovascular Coaching Program Through Lark Health
PALM SPRINGS, Calif. and MOUNTAIN VIEW, Calif., March 31, 2022 /PRNewswire/ — Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, and Lark Health today announced that DOHC will offer Lark Heart Health, a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease (ASCVD) and coronary artery disease (CAD). Together, DOHC and Lark will […]
Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606
PARIS, March 31, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announced the publication of a new scientific article reporting the efficacy of its second drug-candidate, […]
Cipherome, Inc. Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
American Heart Association consortium advances development of evidence-based health tech solutions SAN JOSE, Calif.–(BUSINESS WIRE)–Cipherome, Inc. (“Cipherome”), a Silicon Valley-based, genomic bioinformatics start-up, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships […]
Shockwave Medical Announces Japanese Regulatory Approval of Coronary IVL
Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s Largest Coronary Intervention Markets SANTA CLARA, Calif., March 30, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that […]
Biome Introduces Next Generation Cardiovascular Performance Solution
The Biome Opportunity Engine™ leverages advanced machine learning to automatically identify and prioritize clinical and financial performance opportunities with the greatest impact on outcomes. SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance company, is pleased to introduce the Biome Opportunity Engine™. This groundbreaking solution enables cardiovascular service lines, at individual […]
Recent
Popular
- No commented posts yet